Discover 1,443 paid clinical trials in Everett, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,443
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
Location: Seattle WA, Portland OR, Los Angeles CA, St Louis MO,
Sponsor: Sun Pharmaceutical Industries Limited
Sex: Male
Age: 18+
Code: NCT05422911
Phase 2, Recruiting
A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Seattle WA, San Francisco CA, Kansas City MO, Durham NC
Sponsor: VA Office of Research and Development
Sex: All
Age: 18 - 70+
Code: NCT06520098
Phase 2, Recruiting
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
for
PTSD, Obesity
Location: Seattle WA
Sponsor: VA Office of Research and Development
Sex: All
Age: 18+
Code: NCT07010757
Recruiting
Evaluating Treatments for Suicidal Veterans With PTSD
Location: Seattle WA, Aurora CO, Minneapolis MN, Ann Arbor MI,
Sponsor: VA Office of Research and Development
Sex: All
Age: 21 - 55
Code: NCT04867317
Phase 3, Recruiting
Evaluation of the PE Coach Mobile Application Among Veterans With PTSD
for
Posttraumatic Stress Disorder
Location: Seattle WA
Sponsor: VA Office of Research and Development
Sex: All
Age: 18 - 65
Code: NCT04959695
Recruiting
Pacific Northwest Udall Center (PANUC) Clinical Core
for
Parkinson Disease, Cognitive Impairment
Location: Seattle WA
Sponsor: University of Washington
Sex: All
Age: 18+
Code: NCT01720810
Recruiting
New
Pharmacist-Led Treat-to-Target Urate Lowering Therapy in Patients With Gout
for
Gout, Gouty Arthritis
Location: Seattle WA, Portland OR, Salt Lake City UT, Omaha NE,
Sponsor: VA Office of Research and Development
Sex: All
Age: 18+
Code: NCT06887452
Recruiting
Testosterone Replacement in Male Cancer Survivors With Fatigue and Low Testosterone
for
Hypogonadism, Male, Fatigue Syndrome, Chronic
Location: Seattle WA, Boston MA
Sponsor: Seattle Institute for Biomedical and Clinical Research
Sex: Male
Age: 18 - 54
Code: NCT04049331
Phase 2, Recruiting
Evaluating the Uptake and Utility of Clinical Pathways for Newly Diagnosed Patients With Multiple Myeloma
for
Multiple Myeloma, Multiple Myeloma Without Mention of Remission
Location: Seattle WA
Sponsor: All4Cure
Sex: All
Age: 18+
Code: NCT06149910
Recruiting
Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer
for
Advanced Breast Cancer
Location: Tacoma WA, Glendale CA, Los Angeles CA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06380751
Phase 3, Recruiting
AIMS Cancer Outcomes Study
for
Neoplasms, Neoplasm Malignant, Advanced Cancer,
Location: Seattle WA
Sponsor: Advanced Integrative Medical Science Institute
Sex: All
Age: 0+
Code: NCT04495790
Recruiting
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
for
HIV Infections
Location: Seattle WA, Bakersfield CA, West Hollywood CA,
Sponsor: ViiV Healthcare
Sex: All
Age: 18+
Code: NCT07202546
Phase 2, Recruiting
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
for
Solid Tumors
Location: Seattle WA, Olympia WA, San Francisco CA,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT07522073
Phase 3, Recruiting
A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults
for
Influenza, Human+COVID-19
Location: Seattle WA, Fair Oaks CA, San Diego CA, Austin TX,
Sponsor: GlaxoSmithKline
Sex: All
Age: 65 - 70+
Code: NCT07464314
Phase 1, Recruiting
A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)